California Trim Clinic Review

What California Trim Clinic charges

• Semaglutide: $199/mo — starting at, per month, carrying an asterisk whose footnote states a three-month term — on a page headed "Without Membership Fees or Automatic Renewals"
• Tirzepatide: $299/mo — starting at, per month, with the same three-month footnote

California Trim Clinic also sells 11 compounds this site boards without publishing a price for them: Sermorelin, Ipamorelin (board ranks no provider), CJC-1295 (board ranks no provider), Tesamorelin, NAD+, BPC-157 (board ranks no provider), TB-500 (board ranks no provider), GHK-Cu, MOTS-C (board ranks no provider), Semax (board ranks no provider) and Epitalon (board ranks no provider).

Read the asterisk

Both weight-loss figures carry an asterisk. The footnote, in capitals immediately beneath them, requires a three-month treatment commitment.

The same page is headed with a promise of no membership fees and no automatic renewals, and adds that there is no subscription trap.

None of those claims is false on its own terms — a fixed three-month course is not a subscription — but a reader who takes the monthly figure at face value will commit to three times it.

Thirteen peptides, no prices

Its compounded peptide therapy page names thirteen compounds this site tracks, each with a short description and an eligibility link.

Not one of them carries a figure. Every route to a price runs through an eligibility check.

So this seller sits on the roster with the widest unpriced peptide menu in this pass and two priced weight-loss drugs.

Research language on a prescription page

Several peptide descriptions use the vocabulary of research — a compound available for metabolic research, a combination for regenerative research, longevity research implications.

That wording is worth naming because it is the vocabulary of the grey market, and it is not what this seller is: the same page says doctor-prescribed and pharmacy-compounded, and that compounded medications are prepared for patient-specific use pursuant to an individual prescription.

It is recorded here as a description of the marketing, not as a finding about what is sold.

What it does and does not disclose

It says compounded medications are not FDA-approved and should only be used under guidance.

It names the city its practice is based in rather than only claiming to be nationwide.

No state list is published, no dispensing pharmacy is named, and no certificate of analysis is reachable.

How we verified this

• Read the footnote attached to both advertised figures and recorded the three-month commitment in the qualifier on each price.
• Read the peptide therapy page compound by compound and confirmed no figure appears against any of the thirteen.
• Read the research vocabulary in context and confirmed the same page describes the offering as doctor-prescribed and pharmacy-compounded, rather than treating the wording as evidence of a research-only seller.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand against the live federal warning-letter table, filtering locally because the table's own search parameter returns every record whatever is typed into it, with a positive and a nonsense control in the same run.